Patents by Inventor Fanny Caciularu

Fanny Caciularu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FORMULATIONS OF LADOSTIGIL TARTRATE
    Publication number: 20110301234
    Abstract: The invention relates to a pharmaceutical composition of R(+)-6-(N-methyl,N-ethyl-carbamoyloxy)-N?-propargyl-1-aminoindan ½ tartrate, at least one pharmaceutically acceptable excipient and up to 5% by weight of the composition of water. The composition is typically in a solid oral form which upon administration to a human subject provides a maximum blood plasma concentration of R(+)-6-(N-methyl,N-ethyl-carbamoyloxy)-N?-propargyl-1-aminoindan of at least 0.7 nmol/mL.
    Type: Application
    Filed: August 17, 2011
    Publication date: December 8, 2011
    Inventors: Daniella Licht, Ioana Lovinger, Fanny Caciularu, Adrian Gilbert
  • Formulations of ladostigil tartrate
    Patent number: 8022104
    Abstract: Disclosed are formulations of ladostigil tartrate, including pharmaceutical compositions, process for the manufacture, and use thereof.
    Type: Grant
    Filed: February 24, 2006
    Date of Patent: September 20, 2011
    Assignees: Yissum Research Development Company of the Hebrew University of Jerusalem, Technion Research and Development Foundation Ltd.
    Inventors: Daniella Licht, Ioana Lovinger, Fanny Caciularu, Adrian Gilbert
  • Rasagiline soft gelatin capsules
    Publication number: 20100008983
    Abstract: Disclosed are formulations which are designed to release rasagiline mesylate while maintaining specific pharmacokinetic properties.
    Type: Application
    Filed: June 10, 2009
    Publication date: January 14, 2010
    Inventors: Muhammad Safadi, Daniella Licht, Marina Zholkovsky, Fanny Caciularu, Tomas Andrysek, Ales Vrana, Marie Elblova, Roman Stonis
  • Formulations of ladostigil tartrate
    Publication number: 20060189685
    Abstract: Disclosed are formulations of ladostigil tartrate, including pharmaceutical compositions, process for the manufacture, and use thereof.
    Type: Application
    Filed: February 24, 2006
    Publication date: August 24, 2006
    Inventors: Daniella Licht, Ioana Lovinger, Fanny Caciularu, Adrian Gilbert
  • Stable compositions containing N-propargyl-1-aminoindan
    Patent number: 6126968
    Abstract: A pharmaceutical composition comprising as active ingredient a racemic, S(-), and R(+)-N-propargyl-1-aminoindan or a pharmaceutically acceptable salt thereof, and at least 60% by weight of at least one pentahydric or hexahydric alcohol. Optionally the composition may contain citric acid and magnesium stearate.
    Type: Grant
    Filed: February 22, 1999
    Date of Patent: October 3, 2000
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Tirtsah Berger Peskin, Fanny Caciularu